Background: Mushrooms have been widely used as medicinal products. In developed countries, only in the past few decades, special attention has been given to dietary supplements as sources to improve health and wellness. Aim of the study: This review critically assessed the mode of action of mushrooms, their extracts and biomass, following our research on mode of action, efficacy and safety of mushroom nutrition. Results: The nutritional role of mushroom products, as indirect probiotics, as direct prebiotics or as both (synbiotics), is justified by their influence on the inflammation process and on the gut microbioma through their contents of β-glucans, enzymes, and secondary metabolites. A possible new concept is advanced, that ultra-trace elements (e.g. germanium) may play an eventual prebiotic complementary role on the mode of action of mushrooms. Conclusion: The special properties of mushrooms along with their minimal side effects make them ideal candidates for developing novel dietary supplements and therapies.
Fungi are a group of eukaryotic organisms that include yeasts, moulds and mushrooms, and are major decomposers in certain ecosystems and essential associates of many organisms. Recent estimates based on high-throughput sequencing methods suggest that as many as 5.1 million fungal species exist. Some 14,000 species of fungi can be considered as mushrooms, and at least 2,000 species have been identified as edible.
Mushrooms are appreciated for their nutritional value and health properties. Medicinal mushrooms, used for millennia as healing tools due to their acclaimed but unexplainable and peculiar impact on well-being, have only recently been the subject of scientific evaluation in the western world. Mushrooms are producers of bioactive molecules, phenolic and antioxidant compounds, valuable enzymes and substantial amount of dietary fibres with specific different therapeutic effects 1, 2 and more than 120 remedial consequences of these molecules have been disclosed 3.
The term prebiotic was coined in 1995 4 to describe the fact that non-digestible food ingredients have beneficial effects on the host by selectively stimulating the growth and/or activity of one or a limited number of bacterial species already resident in the colon, and thus attempt to improve host health.
Prebiotics are non-digestible food ingredients, mainly fibrous polysaccharides that stimulate the growth of lactic acid bacteria and bifidobacteria in the gastro-intestinal tract and have a beneficial effect on the host by selectively stimulating the activity of these bacteria in the colon 5. However, this definition would be more precise if, besides food, it referred to nutrients since organic trace mineral sources, such as proteinate and amino acid chelates, copper and zinc may also be considered as prebiotics 6, 7.
Mushrooms are a source of potential prebiotic substrate and all mushroom species bioaccumulates prebiotic trace minerals copper and zinc 8. As they contain many different polysaccharides such as β-glucans and hemicelluloses, mushrooms fulfil the potential for a new concept: a combination of synbiotic effect of targeted pre- and probiotic sources. Well studied mushroom polysaccharides, β-[1→3]-D-glucans 9 and their peptide/protein derivates (PSK and PSP, polysaccharide-peptide/protein complexes) and mucoproteins (formed by glycosaminoglycans covalently attached to core proteins), are essential prebiotics found to play a vital role in immunomodulation and antitumour activities 10, 11, 12. β-glucans are glucose polymers absent in humans but constituents of plants and the cell wall of certain pathogenic bacteria and fungi 13.
They play a role in common colds, influenza, allergies, hepatitis, Lyme disease, ulcerative colitis, cancer, cholesterol, HIV, ear infections, aging, ulcerative colitis, Crohn's disease, diabetes, fibromyalgia, rheumatoid arthritis and multiple sclerosis 14, 15, 16, 17, all through increase of the immune system function 18 (Figure 1).
Many of these compounds with carcinostatic activity 19, may be consumed as part of the normal diet and may have been modified/enriched in some way to provide health-giving benefits 20, 21. The nutritional role of mushroom products, extracts or biomass, as indirect probiotics, as direct prebiotics or as both (synbiotics), is presently justified by their influence on the inflammation process and on the gut microbioma through their content in fibre (β-glucans), enzymes, and secondary metabolites.
Although the underlying causes of inflammation and its role on harmful health effects remain largely unrevealed, it is clear that it contributes to several diseases. Nevertheless, the importance of chronic low-grade inflammation in older people on the onset of numerous unfavourable age-related conditions is now evident 4, 22.
The role of β-glucans on oxidative stress, inflammation, immunological reactions and neurological impact has been demonstrated on many diseases 23. All studies, mainly Asian, were based on the concept of the specific polysaccharide content. Here we advance the possible notion of metalloid germanium being responsible for mushroom mode of action.
The unique property of mushroom polysaccharides to be non-digestible, increases their likelihood to be prospective prebiotics. Some findings provide insight into the mechanisms by which host-dietary fibre-microbe interactions establish immunological homeostasis in the gut and systemic autoimmunity 24, 25.
People who eat diets high in fibre have lower circulating markers of inflammation in their blood. Host defence mechanism involves inflammation to eliminate pathogens from the site of infection, resolution and restoration of tissue homeostasis 26. Inflammation, a defence mechanism that is vital to health, means how activated the immune system is and many different immune cells can take part in this process by releasing different substances, the inflammatory mediators 27, 28, 29.
Narrowing the diet, as often happens in old adults, can result in the shrinking of gut microbiome 30. Diversity is the key and the microbiota of people on narrow diversity diets, such as in developing countries, may collapse. A change in diet in a short time modifies considerably the microbiota pattern, although it reverts rapidly as soon as the diet is discarded 31. The majority (over 80%) of a person's gut microbiota is postulated to be transmitted from maternal microorganisms to offspring during gestation. New-born and child microbial colonization sets the stage for the adult microbiota; bacteria species in the colon at adult stage are more or less the same as when aged 6 months old 32, 33.
We have previously studied the ability of mushroom diet or supplements to positively modulate inflammation as unresolved inflammatory process 34.
2.1. Gut Microbiota and FibreMost human major diseases have a physiological, environmental or lifestyle base, but it is likely that gut microbiota may interact and share the overall risk as they coevolve during their lifetime. Since the 50’s, short chain fatty acids-SCFAs (acetic, propionic, butyric) are well known metabolites in ruminant and equine nutrition, production and metabolism 35. SCFAs activate intestinal gluconeogenesis via a gut-brain neural circuit 36, which can have beneficial effects on glucose and energy homeostasis 37, 38.
The benefits, in humans, of consuming fibrous rich diets and how volatile SCFAs associated with these diets can improve the health of gut microbiota, have also been extensively studied 39, 40, 41. Gut microbiota yields vitamins and exogenous fibre-degrading carbohydrases. The human body, by definition, does not produce vitamins (e.g. B group vitamins: riboflavin, folate and thiamine) nor enzymes able to degrade cellulose and hemicelluloses, which is accomplished by gut bacteria.
Another important role of gut microbiota is their interaction with xenobiotics (e.g. dioxins and polychlorinated biphenyls), including persistent organic pollutants and foodborne chemicals, which may disrupt microbial digestion and impact on host homeostasis 42, 43. It remains unclear how quickly and reproducibly gut bacteria respond to dietary changes.
The balance of microbiota profile is crucial for human well-being, health and disease prevention 44, 45. Because of its resident microbiota, the human colon is one of the body’s most metabolically active organs since colonic bacteria itself is considered to function as an organ 46. However, due to the dynamic and complex nature of the human gut microbiota ecosystem it is difficult to understand the future microbiome composition 47, 48.
Prebiotics are promising health compounds because they can regulate the structure and number of intestinal flora 49 (Figure 2). Mushrooms are rich in polyphenols and polysaccharides such as α-glucan, β-glucans, chitin, galactans, hemicellulose, mannans and xilans making them suitable for prebiotic use. But not all dietary carbohydrates are prebiotics and the most commonly used are FOS: fructo-oligosaccharides, GOS: galacto-oligosaccharides, XOS: xylo-oligosaccharide, fructans (e.g. inulin) 50.
The most frequently studied β-glucans obtained from mushrooms include lentinan from shiitake mushrooms Lentinus edodes, grifolan from Grifola frondosa, schizophyllan from Schizophyllum commune, SSG from Sclerotinia sclerotiorum, PSK (called also Krestin) and PSP (polysaccharide peptide) from Coriolus versicolor, and β-glucan called pleuran isolated from Pleurotus ostreatus 51, 52.
These β-1,3-D-glucans are used as prebiotic dietary supplements, showing positive effects on the intestines and increasing the resistance of intestinal mucosa to inflammation 53, 54. Protein-bound polysaccharides, PSK and PSP, are extracts from mushroom Coriolus versicolor and have been the subject of extensive research by Asian scientists, being approved as nutraceuticals by Chinese and Japanese Food authorities 55.
The biological activity of these products is related to their immunomodulating properties, which enhance the body’s defences against various forms of infectious diseases, including carcinostatic activity 56. We have performed a safety assessment of Coriolus versicolor biomass as a food supplement which showed the absence of any remarkable adverse effects in rats 57.
Probiotics have been used for as long as people have eaten fermented foods, i.e. dating from 7000 to 6600 BC. The beneficial effect of probiotics is mediated by multiple mechanisms of action such as resistance to low pH in the stomach, competitiveness to microbial species inhabiting the intestinal ecosystem, antagonistic activity towards pathogens (e.g., Helicobacter pylori, Listeria monocytogenes, Clostridium difficile and Salmonella sp.) 58, 59.
Other possible functions include resistance to bacteriocins and acids produced by the endogenic intestinal microbiota and adherence and ability to colonise sites within the gut wall 60.
Lactobacillus, Bifidobacterium, Lactococus, Streptococcus, Bacillus, Enterococcus and yeast Saccharomyces are the most common probiotics and generally considered safe to consume. However, a good probiotic culture must be ingested continuously to have better effects 61.
Mushrooms (e.g. Pleurotus ostreatus, Hericium erinaceus, Coriolus versicolor and Lentinus edodes) can significantly modify intestinal flora composition by promoting the metabolism and proliferation of beneficial microorganisms such as Lactobacilli and Bifidobacteria, as well as by inhibiting pathogenic bacteria such as E. coli, Clostridium and Salmonella 62.
Mushroom ingredients have therefore an indirect probiotic role as they affect the type of microbiota. Gut bacteria feed on mushroom fibre such as β-glucans found in the cell walls of bacteria, fungi, yeasts, algae, lichens, and plants 63, 64.
These polysaccharides act as prebiotics and are sometimes used as herbal medicine with multiple recognized clinical uses of mushroom β-glucans 65, 66. Bacteria feed on dietary fibre. If we do not feed bacteria, they feed off the host, more specifically off the mucus lining in the large intestine. Health-promoting gut microbes besides the production of useful SCFAs yield microcins, which are small protein molecules, retaining their biological activity and effectively improving health-promoting properties 67, 68, 69.
4.1. The Immunoceutical Role of MushroomsThe immune system is a network of special cells, tissues, proteins, and organs that work together to protect the body from potentially damaging foreign invaders and disease. A lot remains unexplained about immune function and immune system misconceptions and myths are frequent, while industries take advantage to explore them. The idea of boosting immunity is tempting, but the capability to accomplish has proved deceptive for various reasons 29.
The immune system is precisely a system, not a single entity and it is highly individual and of complex nature, which is almost as specific to each individual as are fingerprints 70. To function well, it requires stability, equilibrium and harmony and depends on age, lifestyle, and stress, exercise and diet although there are no scientific evidences of direct links between many lifestyle habits and variations of immune function. It is a fact that there are no medications to date that directly increase the activity of the immune system. Complementary or alternative products have been researched towards this objective 71.
Mushrooms seem to be a potential source for prebiotic compounds displaying immunomodulation and antitumour activity similar to those resulted from immune effector cells 72, 73, 74.
Edible mushrooms may be a potential source of natural antioxidants with free radical scavenging properties for application as a functional food ingredient. A large part of phenolic compounds (e.g. gallic acid) are associated with the presence of polysaccharides, and they are released in the colon following the fermentative actions 75.
On the onset of a common infection, the innate immune is promptly activated, through macrophages and neutrophils as the true maestros of resolution and regeneration, contributing crucially to the activation of adaptive immunity and controlling common infections 76.
Mushrooms play essential roles in innate and adaptive immunity, by enhancing the body's own use of macrophages, NK-natural killer cells and T-lymphocytes, rather than directly attacking any tumours 77, 78. The immune response regulation also affects anti-tumour properties. The immune response to β-glucans could be in part non-specific and determined by size rather than by chemical structure 79.
Mushrooms contain a mixture of β-1,3-glucan and β-1,6-glucan 80. Macrophages in the mucous lining of the intestinal wall pick up the β-glucan particles through the β-glucan receptors. Absorbed through the intestinal cell wall into the lymph, they suffer macrophage phagocytosis and the immune function is activated 81, 82.
A synbiotic product is a combination of pro- and prebiotics as food ingredient or dietary supplement in a form of synergism, hence synbiotics, to enhance human and animal health. However, the FAO recommends that the term "synbiotic" be used only if the net health benefit is synergistic i.e. when one pre- or probiotic really increases the other’s effectiveness 62.
The most common synbiotic is the combination of Bifidobacterium or Lactobacillus bacteria with FOS-fructooligosaccharides. A prebiotic compound must have the capacity not to be digested or absorbed in the small intestine neither by the host nor by bacteria, and pass into the caecum unaltered, where selectively it will be used by probiotics 83. Long-term consumption of a synbiotic formulation with Lactobacillus fermentum (probiotic) and β-glucan from cauliflower mushroom Sparassis Crispa (prebiotic) prevented menopausal symptoms and improved the gut microbiota 84.
It is critical to recognize that there are an immense variety of probiotics with strain-specific effects, which makes it clear that extrapolations on benefits and harms cannot be made among available products 85.
5.1. Factors behind the Health Benefits of MushroomsGinseng, aloe vera, broccoli, celery, comfrey, goji berry, chamomile, garlic, cumin, ginkgo, ginger, paprika, microalgae, seaweeds, shiitake mushrooms, green tea, watercress, leafy vegetables, and many other natural and fermented foods are regularly recommended by nutritional and healthcare practitioners. Their role as antioxidants is consensus despite the miscellaneous variety of proposed mechanisms of action 86, 87, 88.
For thousands of years, humans have turned to mushrooms that have mysterious abilities on healthcare. Some of 55 major nutrients and energy sources have been well described, however, thousands of other elements are consumed including over 100,000 phytonutrients and vast number of trace elements. Only in milk more than 600 fatty acids have been identified.
This is the reason for encouraging food diversity as being the most adequate way of balancing nutrient and micro- and ultra-trace nutrient intake. Therefore, caution must be taken when pinpointing factors and mode of action when reporting the beneficial impact of any foodstuff (Figure 3).
Although mushrooms have been reasonably described for their β-glucans content they are not the cure-all that some people and firms claim, and why they work so well in several health problems is still under research and debate.
Indeed, no specific food has been acknowledged by scientists and government regulatory authorities as providing a health benefit.
Less than five decades ago many essential minerals were believed to be irrelevant to human metabolism and health and are now considered vitally important. While some metals, e.g., Fe, Co, Mo, Mn, Ni, Se, V and Zn, are essential nutrients for bacterial growth, microbiota interacts and processes metals and metalloids. Hence, since the 70s, bioinorganic chemistry or microbial biogeochemistry dedicated studies on microbial metabolism of inorganic elements.
It is an understanding that individual classes of metabolites cannot be considered in isolation and there are chemical links between different metabolites or chemical structures. Copper and Zinc, which are essential bio-elements, are well bio-concentrated by mushrooms in fruit bodies. Comprehensive studies on bio-concentration of heavy metals (Ag, Al, Ba, Ca, Cd, Co, Cu, Fe, Hg, K, Mg, Mn, Na, Rb, Sr, and Zn) and consumer exposure to mushrooms reveal the importance of Cu and Zn and the natural cycling of these metallic elements in forest ecosystems 89.
The challenge for prebiotic chemistry is to clarify the connections between the various chemical substructures of life and explaining how they can fit together to establish the convolutions that lead to life 90.
Nucleic acids act as informational molecules playing a crucial role in modern biology. A non-enzymatic process through a mineral catalyses the RNA oligomer formation; copper operates as a prebiotic catalyst by interacting with ribonucleotides 91, 92, 93.
The following elements are generally classified as metalloids: boron (B), silicon (Si), germanium (Ge), arsenic (As), antimony (Sb), tellurium (Te), and polonium (Po) (Figure 4). The elements to the upper right of this line display increasing non-metallic behaviour. The elements to the lower left of the line display increasing metallic behaviour.
Metalloids encompass a group of biologically important elements ranging from the essential and beneficial to the highly toxic. Genetic evidence has demonstrated a crucial role for specific major intrinsic proteins (MIPs) in metalloid homeostasis thus suggesting that they could be potential pharmacological targets 94.
The second-most abundant element in the earth’s crust and the third most abundant trace element in human body is silica (the oxide form of silicon), an essential trace mineral for bone density and key ingredient in collagen creation 95. Studies on bioactive beneficial trace elements such as metalloids (e.g. germanium, silica) in foods, plants and mushrooms are scarce and little understood; while it has been suggested that they are essential elements they also have recognised oxic effects 96, 97, 98.
In humans and other mammals the role of metalloids (if any) is less well defined despite being a common dietary trace element 20-50 mg silicon/day is ingested by adults in western populations 99. Silicon is inert and until recently was suggested not to take part in any chemical or biological interactions while in higher plants silicon is up taken and accumulated 100 and interaction with bio-molecules is possible 101.
Factors that determine the flux of silicon in the human body are poorly understood although the absorption and excretion is known not to be dependent on sex and age 102. The oral exposure in humans to a small soluble molecule (orthosilicic acid, Si [OH]4) of silicon did not provide any evidences on the balance of values of intake, excretion and exchange with the body Si pool 103.
The Panel on Food Additives and Nutrient Sources Added to Food of EFSA (European Food Safety Authority) evaluated the ch-OSA (choline-stabilized OrthoSilicic Acid) safety. The objective was to evaluate it as a silicon source and also its bioavailability. However, silicon safety itself, in terms of daily amounts that can be consumed and its classification as a nutrient, was outside the scope of the scientific opinion of EFSA 104.
There are few studies evaluating the safety, efficacy and bioavailability of the different existing chemical forms of silicon that use proper design, large number of volunteers and long follow-up period and much less is actually known on germanium 105.
6.1. The Case of GermaniumGermanium is present in all living plant and animal matter in micro-trace quantities and a comprehensive review of the metabolic distribution, physiological characteristics, biological functions, effects on immunity, germanium deficiency and germanium toxicity have been recently conducted in animals 106.
There are two general forms of germanium: organogermanium compounds, which are carbon-containing compounds (carboxyethyl germanium sesquioxide, spirogermanium, propogermanium, Ge-132); and inorganic (non-carbon containing) germanium compounds (Ge, germanium citrate lactate, germanium dioxide) 107, 108. Elemental germanium is classified as inorganic which is present in all living plant and animal matter in micro-trace quantities 109.
The water soluble, highly stable, non-toxic organic germanium sesquioxide (Ge-132) is an ultra-trace metalloid or semi-metal used in Japan since 1967 but a novel water-soluble food supplement in the Western world 110. Ge-132 is a synthesized form and is quite abundant in garlic and several other foods including mushrooms with significant potential for treating various human illnesses and promoting lifestyle. Since the elements of similar atomic number are biologically-essential trace elements (e.g. selenium), one might anticipate that germanium plays a role in human biochemistry.
Mechanisms by which bacteria dispose of metal pollutants and circumvent their toxic influence have major implications in environmental, medical, and biotechnological domains. This may include the bioremediation of waste sites, chelation therapy, and the production of unique metabolites. Although the concentration of heavy metals in fruiting body of mushrooms and their substrates is well studied, very little still is known on trace and ultra-trace elements and regular consumption of wild-growing mushrooms is discouraged 111.
The first reported study on germanium 112 referred that this metalloid occurs in high concentrations in certain medicinal plants, and that a synthetic derivative appears to have significant clinical efficacy, thus reopening the question of its biological essentiality. This report mentioned concentrations of germanium in foods and other biomaterials ranging from 0.1 to 1 ppm, corresponding to 0.1 to 1 μg germanium/g of food material, quite lower values later determined by others.
Very little information is available on the germanium content of food while well-known and widely used market products (e.g. garlic) have high levels of germanium (Table 1). The average daily intake of germanium for humans has been variously estimated to be from 1.5 to 0.4 mg/day 113.
Despite the existence of an international standard 114, the method applied for determination of germanium in soil, food and water samples has been quite variable therefore the values recorded depend on the method of analysis, the reproducibility among laboratories and several other variables. The observed range of germanium levels varies significantly in the literature most probably due to different methodologies used.
6.2. Activity and Function of GermaniumThe therapeutic effects of organic germanium in a wide range of serious afflictions, have been reported 117, 118. The power of germanium is based on the fact that it increases oxygenation in the body tissues, considered more efficient than vitamin E, discharge accumulated hydrogen and washout of toxic heavy metals. It has also a potent antioxidant activity against hydrogen peroxide-induced oxidative stress although the oxygen modulation mechanisms not yet clear 119. Oral Ge-132 intake increases plasma α-tocopherol levels by up-regulating α-tocopherol transfer protein [Ttpa] gene expression 120.
Just like selenium, inorganic germanium non-carbon containing compounds, i.e. germanium dioxide, germanium citrate lactate, and elemental germanium, are potentially toxic and should not be confused with organic germanium. Because of the possibility of contaminated organic germanium products on the market and several unclear and poor-quality scientific reviews, all types of germanium are currently thought of as unsafe. The high-purity synthetic organic complex of selenium is safe, with much lower toxicity than the inorganic form, and is used as a dietary supplement 53, being totally secreted intact from the body within 48 hours.
Organic germanium compounds are described as antioxidants and inhibiting the progress of cancer and AIDS and destroying cancer cells 121. The organic germanium compound, Ge-132, has immune-modulating effects and is marketed as non-prescription drugs in Europe being recommended by the suppliers for AIDS and metastatic cancer disease 122. The metalloid organic germanium may be a vital element for the ability of mushrooms Ganoderma lucidum and Coriolus cinnabarinus to fight cancer cells 55, 123. The combined effects of Ge-132 with Lactobacilli and oligosaccharide on the immune responses of mice suggest that this combination with a low concentration of Ge-132 stimulates the intestinal immunity 124, 125.
The ingestion of Ge-132 promotes bile secretion 126 and significantly elevates the activities of hepatic superoxide dismutase (SOD) and catalase following herbicide paraquat ingestion. Data clearly demonstrated in rigorous scientific studies that Ge-132 may be useful as an antioxidant detox 127.
Direct use of bioactive phytochemicals from mushrooms (e.g. Coriolus versicolor) for gene vector development was studied to be used as a multi-therapeutic gene carrier for tackling cancers 128. Besides the already well described and established role of these fibrous polysaccharopeptides, we advance with the possibility that other bioactive mushroom ingredients may be responsible for the mechanism of action on health benefits which have not been the subject of much research.
Although germanium supplements have been approved and used in Japan since the 70’s, a proven safe and effective dose for organic germanium needs to be investigated 129 since there are reports demonstrating that dietary supplements of organic germanium may be toxic being evident that germanium products present a potential human health hazard 130, 131, 132, 133.
There are some 2000 mushrooms identified as edible and a large number of the species are yet to be analysed for their nutraceutical/medicinal potential and the determination of germanium in botanical samples is necessary 134.
Mushroom biomass and extracts are good choices for people with an already weakened immune system. They do not perform miracles neither do they have a specific role for each illness, rather, they support the immune system, assisting in preventing or mitigating the effects of a range of several ailments. However, dose setting, safety of use, and toxicological and clinical trials documenting the desired health effects are still necessary.
Current evidence does not support recommendations for or against single-nutrient or trace element supplementation. We have enhanced the need for a new field of research on the content of metalloids in mushrooms and plants with known beneficial health impacts. Only after a successful in vitro and in vivo testing on a wide statistical set of selected population groups and clinical trials, recommendations may be formulated.
There must be in future enlarged policies encouraging the development of common strategies and agendas, internationalisation of clusters among the Western world (EU and USA) with Asian scientific communities (China and Japan). Developing innovation, policy measures, scientific cooperation opportunities, while promoting competitiveness and understanding the huge difference on existing backgrounds among civilizations is necessary.
THF drafted and all authors contributed equally, and declare no conflict of interest and were not paid for the manuscript. No financing was involved.
[1] | Badalyan SM. Potential of mushroom bioactive molecules to develop healthcare biotech products. Proc 8th Int Conf Mushroom Biol Mushroom Prod 2014: 373-8. | ||
In article | |||
[2] | Valverde ME, Hernández-Perez T, Paredes-López O. Edible mushrooms: improving human health and promoting quality life. Int J Microbiol 2013; 2015: 1-14. | ||
In article | View Article PubMed PubMed | ||
[3] | Wasser S. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomed J 2014; 37: 345. | ||
In article | View Article PubMed | ||
[4] | Gibson GR, Probert HM, Loo J Van, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259. | ||
In article | View Article PubMed | ||
[5] | Caporgno MP, Mathys A. Trends in Microalgae Incorporation Into Innovative Food Products With Potential Health Benefits. Front Nutr 2018; 5: 1-10. | ||
In article | View Article PubMed PubMed | ||
[6] | Patel S, Goyal A. The current trends and future perspectives of prebiotics research: a review. 3 Biotech 2012; 2: 115-25. | ||
In article | View Article PubMed | ||
[7] | Singdevsachan SK, Auroshree P, Mishra J, Baliyarsingh B, Tayung K, Thatoi H. Mushroom polysaccharides as potential prebiotics with their antitumor and immunomodulating properties: A review. Bioact Carbohydrates Diet Fibre 2016; 7: 1-14. | ||
In article | View Article | ||
[8] | Rahar S, Swami G, Nagpal N, Nagpal M, Singh G. Preparation, characterization, and biological properties of β-glucans. J Adv Pharm Technol Res 2011; 2: 94. | ||
In article | View Article PubMed PubMed | ||
[9] | Ortiz LT, Rodríguez ML, Alzueta C, Rebolé A, Treviño J. Effect of inulin on growth performance, intestinal tract sizes, mineral retention and tibial bone mineralisation in broiler chickens. Br Poult Sci 2009; 50: 325-32. | ||
In article | View Article PubMed | ||
[10] | Zhang TY, Liu JL, Zhang J, Zhang N, Yang X, Qu H, et al. Effects of Dietary Zinc Levels on the Growth Performance, Organ Zinc Content, and Zinc Retention in Broiler Chickens. Brazilian J Poult Sci 2018; 20: 127-32. | ||
In article | View Article | ||
[11] | Alonso J, García MA, Pérez-López M, Melgar MJ. The concentrations and bioconcentration factors of copper and zinc in edible mushrooms. Arch Environ Contam Toxicol 2003; 44: 180-8. | ||
In article | View Article PubMed | ||
[12] | Davis HC. Can the gastrointestinal microbiota be modulated by dietary fibre to treat obesity? Ir J Med Sci 2018; 187: 393-402. | ||
In article | View Article PubMed | ||
[13] | Fesel PH, Zuccaro A. β-glucan: Crucial component of the fungal cell wall and elusive MAMP in plants. Fungal Genet Biol 2016; 90: 53-60. | ||
In article | View Article PubMed | ||
[14] | Lemieszek M, Rzeski W. Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Wspolczesna Onkol 2012; 16: 285-9. | ||
In article | View Article PubMed PubMed | ||
[15] | El Khoury D, Cuda C, Luhovyy BL, Anderson GH. Beta glucan: Health benefits in obesity and metabolic syndrome. J Nutr Metab 2012; 2012. | ||
In article | |||
[16] | Ren L, Perera C, Hemar Y. Antitumor activity of mushroom polysaccharides: a review. Food Funct 2012; 3: 1118. | ||
In article | View Article PubMed | ||
[17] | Synytsya A, Míčková K, Synytsya A, Jablonský I, Spěváček J, Erban V, et al. Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii: Structure and potential prebiotic activity. Carbohydr Polym 2009; 76: 548-56. | ||
In article | View Article | ||
[18] | Kim SP, Kang MY, Kim JH, Nam SH, Friedman M. Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice. J Agric Food Chem 2011; 59: 9861-9. | ||
In article | View Article PubMed | ||
[19] | Vaz JA, Heleno SA, Martins A, Almeida GM, Vasconcelos MH, Ferreira ICFR. Wild mushrooms Clitocybe alexandri and Lepista inversa: In vitro antioxidant activity and growth inhibition of human tumour cell lines. Food Chem Toxicol 2010; 48: 2881-4. | ||
In article | View Article PubMed | ||
[20] | Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E. Effects of beta-glucans on the immune system. Medicina (Kaunas) 2007; 43: 597-606. | ||
In article | View Article | ||
[21] | Chang ST, Buswell JA. Mushroom nutriceuticals. World J Microbiol Biotechnol 1996; 12: 473-6. | ||
In article | View Article PubMed | ||
[22] | Tomita M, Miwa M, Ouchi S, Oda T, Aketagawa J, Goto Y, et al. Nonlinear intestinal absorption of (1-->3)-beta-D-glucan caused by absorptive and secretory transporting system. Biol Pharm Bull 2009; 32: 1295-7. | ||
In article | View Article PubMed | ||
[23] | Georgia Department of Public Health. Contribution of inflammation to several diseases. Stat Georg 2017. https://www.statistics.ge/statistics-on-inflammation/(accessed March 23, 2018). | ||
In article | |||
[24] | Grigg JB, Sonnenberg GF. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol 2017; 198: 564-71. | ||
In article | View Article PubMed PubMed | ||
[25] | Senghor B, Sokhna C, Ruimy R, Lagier J-C. Gut microbiota diversity according to dietary habits and geographical provenance. Hum Microbiome J 2018; 7-8: 1-9. | ||
In article | View Article | ||
[26] | Thorburn AN, Macia L, Mackay CR. Diet, Metabolites, and “Western-Lifestyle” Inflammatory Diseases. Immunity 2014; 40: 833-42. | ||
In article | View Article PubMed | ||
[27] | Silva V de O, Pereira LJ, Murata RM. Oral microbe-host interactions: influence of β-glucans on gene expression of inflammatory cytokines and metabolome profile. BMC Microbiol 2017; 17: 53. | ||
In article | View Article PubMed PubMed | ||
[28] | North CJ, Venter CS, Jerling JC. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 2009; 63: 921-33. | ||
In article | View Article PubMed | ||
[29] | Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018; 9: 7204-18. | ||
In article | View Article | ||
[30] | Scully C, Georgakopoulou EA, Hassona Y. The Immune System: Basis of so much Health and Disease: 3. Adaptive Immunity. Dent Update 2017; 44: 322-4, 327. | ||
In article | View Article PubMed | ||
[31] | Heiman ML, Greenway FL. A healthy gastrointestinal microbiome is dependent on dietary diversity. Mol Metab 2016; 5: 317-20. | ||
In article | View Article PubMed PubMed | ||
[32] | Soty M, Penhoat A, Amigo-Correig M, Vinera J, Sardella A, Vullin-Bouilloux F, et al. A gut-brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic health. Mol Metab 2015; 4: 106-17. | ||
In article | View Article PubMed PubMed | ||
[33] | Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, et al. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiol Mol Biol Rev 2017; 81. | ||
In article | View Article | ||
[34] | Trovato A, Pennisi M, Crupi R, Paola R Di, Alario A, Modafferi S, et al. Neuroinflammation and Mitochondrial Dysfunction in the Pathogenesis of Alzheimer’s Disease: Modulation by Coriolus Versicolor (Yun-Zhi) Nutritional Mushroom. J Neurol Neuromed 2017; 2: 19-28. | ||
In article | View Article | ||
[35] | Annison EF, Bryden WL. Perspectives on ruminant nutrition and metabolism I. Metabolism in the Rumen. Nutr Res Rev 1998; 11: 173-98. | ||
In article | View Article PubMed | ||
[36] | David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-63. | ||
In article | View Article PubMed PubMed | ||
[37] | Ohira H, Tsutsui W, Fujioka Y. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? J Atheroscler Thromb 2017; 24: 660-72. | ||
In article | View Article PubMed PubMed | ||
[38] | Hur KY, Lee MS. Gut Microbiota and Metabolic Disorders. Diabetes Metab J 2015; 39: 198-203. | ||
In article | View Article PubMed PubMed | ||
[39] | den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013; 54: 2325-40. | ||
In article | View Article PubMed PubMed | ||
[40] | Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol 2016; 7: 185. | ||
In article | View Article PubMed PubMed | ||
[41] | Tuncil YE, Thakkar RD, Marcia ADR, Hamaker BR, Lindemann SR. Divergent short-chain fatty acid production and succession of colonic microbiota arise in fermentation of variously-sized wheat bran fractions. Sci Rep 2018; 8: 16655. | ||
In article | View Article PubMed PubMed | ||
[42] | Defois C, Ratel J, Garrait G, Denis S, Le Goff O, Talvas J, et al. Food Chemicals Disrupt Human Gut Microbiota Activity And Impact Intestinal Homeostasis As Revealed By In Vitro Systems. Sci Rep 2018; 8: 11006. | ||
In article | View Article PubMed PubMed | ||
[43] | Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, Nebot C, Cardelle-Cobas A, Franco CM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota—a review. J Physiol Biochem 2018; 74: 69-83. | ||
In article | View Article PubMed | ||
[44] | Jiang H, Zhang X, Yu Z, Zhang Z, Deng M, Zhao J, et al. Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res 2018; 104: 130-6. | ||
In article | View Article PubMed | ||
[45] | Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, et al. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer Res 2017; 77: 1783-812. | ||
In article | View Article PubMed PubMed | ||
[46] | O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688-93. | ||
In article | View Article PubMed PubMed | ||
[47] | Shenhav L, Furman O, Mizrahi I, Halperin E. Modeling the temporal dynamics of the gut microbial community in adults and infants. BioRxiv 2017: 212993. | ||
In article | View Article | ||
[48] | Sung J, Kim S, Cabatbat JJT, Jang S, Jin Y-S, Jung GY, et al. Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis. Nat Commun 2017; 8: 15393. | ||
In article | View Article PubMed PubMed | ||
[49] | de Jesus Raposo MF, de Morais AMMB, de Morais RMSC. Emergent Sources of Prebiotics: Seaweeds and Microalgae. Mar Drugs 2016; 14. | ||
In article | View Article | ||
[50] | Yamaguchi M, Yang Y, Ando M, Kumrungsee T, Kato N, Okazaki Y. Increased intestinal ethanol following consumption of fructooligosaccharides in rats. Biomed Reports 2018; 9: 427-32. | ||
In article | View Article | ||
[51] | Hozová B, Kuniak Ľ, Kelemenová B. Application of beta-D-glucans isolated from mushrooms Pleurotus ostreatus (Pleuran) and Lentinus edodes (Lentinan) for increasing the bioactivity of yoghurts. Czech J Food Sci 2011; 22: 204-14. | ||
In article | View Article | ||
[52] | Ayeka PA. Potential of Mushroom Compounds as Immunomodulators in Cancer Immunotherapy: A Review. Evidence-Based Complement Altern Med 2018; 2018: 1-9. | ||
In article | View Article PubMed PubMed | ||
[53] | Wang Y. Prebiotics: Present and future in food science and technology. Food Res Int 2009; 42: 8-12. | ||
In article | View Article | ||
[54] | Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (basidiomycetes: polyporaceae). Gen Pharmacol 1998; 30: 1-4. | ||
In article | View Article | ||
[55] | Saleh MH, Rashedi I, Keating A. Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide. Front Immunol 2017; 8: 1087. | ||
In article | View Article PubMed PubMed | ||
[56] | Chatterjee S, Biswas G, Basu SK, Acharya K. Antineoplastic effect of mushrooms: A review. Aust J Crop Sci 2011; 5: 904-11. | ||
In article | |||
[57] | Barros AB, Ferrão J, Fernandes T. A safety assessment of Coriolus versicolor biomass as a food supplement. Food & Nutrition Res 2016; 60: 1-7. | ||
In article | View Article PubMed PubMed | ||
[58] | Javanmard A, Ashtari S, Sabet B, Davoodi SH, Rostami-Nejad M, Esmaeil Akbari M, et al. Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview. Gastroenterol Hepatol from Bed to Bench 2018; 11: 284-95. | ||
In article | PubMed PubMed | ||
[59] | Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 2001; 73: 399s-405s. | ||
In article | View Article PubMed | ||
[60] | Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001; 413: 36-7. | ||
In article | View Article PubMed | ||
[61] | Larone DH. Medically important fungi. 4th ed. USA: 2002. | ||
In article | PubMed | ||
[62] | Pandey KR, Naik SR, Vakil B V. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol 2015; 52: 7577-87. | ||
In article | View Article PubMed PubMed | ||
[63] | Barclay D V., Schrezenmeir J, Scholz-Ahrens KE, Adolphi B, Açil Y, Rochat F, et al. Effects of probiotics, prebiotics, and synbiotics on mineral metabolism in ovariectomized rats — impact of bacterial mass, intestinal absorptive area and reduction of bone turn-over. NFS J 2016; 3: 41-50. | ||
In article | View Article | ||
[64] | Jayachandran M, Chen J, Chung SSM, Xu B. A critical review on the impacts of β-glucans on gut microbiota and human health. J Nutr Biochem 2018; 61: 101-10. | ||
In article | View Article PubMed | ||
[65] | Khan AA, Gani A, Khanday FA, Masoodi FA. Biological and pharmaceutical activities of mushroom β-glucan discussed as a potential functional food ingredient. Bioact Carbohydrates Diet Fibre 2018; 16: 1-13. | ||
In article | View Article | ||
[66] | Ercolini D, Fogliano V. Food Design To Feed the Human Gut Microbiota. J Agric Food Chem 2018; 66: 3754-8. | ||
In article | View Article PubMed PubMed | ||
[67] | Shanahan F, van Sinderen D, O’Toole PW, Stanton C. Feeding the microbiota: transducer of nutrient signals for the host. Gut 2017; 66: 1709-17. | ||
In article | View Article PubMed | ||
[68] | Nabhani Z, Hezaveh SJG, Razmpoosh E, Asghari-Jafarabadi M, Gargari BP. The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial. Diabetes Res Clin Pract 2018; 138: 149-57. | ||
In article | View Article PubMed | ||
[69] | Deshpande GC, Rao SC, Keil AD, Patole SK. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med 2011; 9: 92. | ||
In article | View Article PubMed PubMed | ||
[70] | Nicholson LB. The immune system. Essays Biochem 2016; 60: 275-301. | ||
In article | View Article PubMed PubMed | ||
[71] | Vetvicka V, Dvorak B, Vetvickova J, Richter J, Krizan J, Sima P, et al. Orally administered marine (1 → 3)-β-d-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 2007; 40: 291-8. | ||
In article | View Article PubMed | ||
[72] | Novak M, Vetvicka V. β -Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of Action. J Immunotoxicol 2008; 5: 47-57. | ||
In article | View Article PubMed | ||
[73] | Tang J, Lin G, Langdon WY, Tao L, Zhang J. Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity. Front Immunol 2018; 9: 123. | ||
In article | View Article PubMed PubMed | ||
[74] | Guo Y, Chang Q, Cheng L, Xiong S, Jia X, Lin X, et al. C-Type Lectin Receptor CD23 Is Required for Host Defense against Candida albicans and Aspergillus fumigatus Infection. J Immunol 2018; 201: 2427-40. | ||
In article | View Article PubMed | ||
[75] | Bohn JA, BeMiller JN. (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym 1995; 28: 3-14. | ||
In article | View Article | ||
[76] | Albeituni SH, Yan J. The effects of β-glucans on dendritic cells and implications for cancer therapy. Anticancer Agents Med Chem 2013; 13: 689-98. | ||
In article | View Article | ||
[77] | Chan G, Chan W, Sze D. The effects of β-glucan on human immune and cancer cells. J Hematol Oncol 2009; 2: 25. | ||
In article | View Article PubMed PubMed | ||
[78] | Ruthes AC, Smiderle FR, Iacomini M. D-Glucans from edible mushrooms: A review on the extraction, purification and chemical characterization approaches. Carbohydr Polym 2015; 117: 753-61. | ||
In article | View Article PubMed | ||
[79] | So J-S. Roles of Endoplasmic Reticulum Stress in Immune Responses. Mol Cells 2018; 41: 705-16. | ||
In article | PubMed PubMed | ||
[80] | Cheung PCK. Mini-review on edible mushrooms as source of dietary fiber: Preparation and health benefits. Food Sci Hum Wellness 2013; 2: 162-6. | ||
In article | View Article | ||
[81] | Naimi S, Zirah S, Hammami R, Fernandez B, Rebuffat S, Fliss I. Fate and Biological Activity of the Antimicrobial Lasso Peptide Microcin J25 Under Gastrointestinal Tract Conditions. Front Microbiol 2018; 9: 1764. | ||
In article | View Article PubMed PubMed | ||
[82] | Lenfestey MW, Neu J. Gastrointestinal Development: Implications for Management of Preterm and Term Infants. Gastroenterol Clin North Am 2018; 47: 773-91. | ||
In article | View Article | ||
[83] | Chamidah A. Stability of prebiotic, laminaran oligosaccharide under food processing conditions. IOP Conf Ser Earth Environ Sci 2018; 137: 012069. | ||
In article | View Article | ||
[84] | Jeong S-Y, Kang S, Hua CS, Ting Z, Park S. Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats. Genes Nutr 2017; 12: 31. | ||
In article | View Article PubMed PubMed | ||
[85] | Falandysz J. Selenium in Edible Mushrooms. J Environ Sci Heal Part C 2008; 26: 256-99. | ||
In article | View Article PubMed | ||
[86] | Gucia M, Jarzyńska G, Rafał E, Roszak M, Kojta AK, Osiej I, et al. Multivariate analysis of mineral constituents of edible Parasol Mushroom (Macrolepiota procera) and soils beneath fruiting bodies collected from Northern Poland. Environ Sci Pollut Res 2012; 19: 416-31. | ||
In article | View Article PubMed PubMed | ||
[87] | Kitadai N, Maruyama S. Origins of building blocks of life: A review. Geosci Front 2018; 9: 1117-53. | ||
In article | View Article | ||
[88] | Roberts SJ, Szabla R, Todd ZR, Stairs S, Bučar D-K, Šponer J, et al. Selective prebiotic conversion of pyrimidine and purine anhydronucleosides into Watson-Crick base-pairing arabino-furanosyl nucleosides in water. Nat Commun 2018; 9: 4073. | ||
In article | View Article PubMed PubMed | ||
[89] | Jamnická G, Vál’ka J, Bublinec E. Heavy metal accumulation and distribution in forest understory herb species of Carpathian beech ecosystems. Chem Speciat Bioavailab 2013; 25: 209-15. | ||
In article | View Article | ||
[90] | Falandysz J, Mędyk M, Treu R. Bio-concentration potential and associations of heavy metals in Amanita muscaria (L.) Lam. from northern regions of Poland. Environ Sci Pollut Res Int 2018; 25: 25190-206. | ||
In article | View Article PubMed PubMed | ||
[91] | Falandysz J, Sapkota A, Dryżałowska A, Mędyk M, Feng X. Analysis of some metallic elements and metalloids composition and relationships in parasol mushroom Macrolepiota procera. Environ Sci Pollut Res Int 2017; 24: 15528-37. | ||
In article | View Article PubMed PubMed | ||
[92] | Bienert GP, Schüssler MD, Jahn TP, Jahn T. Metalloids: essential, beneficial or toxic? Major intrinsic proteins sort it out. Trends Biochem Sci 2008; 33: 20-6. | ||
In article | View Article PubMed | ||
[93] | Jugdaohsingh R. Silicon and bone health. J Nutr Health Aging 2007; 11: 99-110. | ||
In article | PubMed PubMed | ||
[94] | Nielsen FH. Update on the possible nutritional importance of silicon. J Trace Elem Med Biol 2014; 28: 379-82. | ||
In article | View Article PubMed | ||
[95] | Pérez-Granados AM, Vaquero MP. Silicon, aluminium, arsenic and lithium: essentiality and human health implications. J Nutr Health Aging 2002; 6: 154-62. | ||
In article | PubMed | ||
[96] | Sanders OI, Rensing C, Kuroda M, Mitra B, Rosen BP. Antimonite is accumulated by the glycerol facilitator GlpF in Escherichia coli. J Bacteriol 1997; 179: 3365-7. | ||
In article | View Article PubMed PubMed | ||
[97] | McNaughton SA, Bolton-Smith C, Mishra GD, Jugdaohsingh R, Powell JJ. Dietary silicon intake in post-menopausal women. Br J Nutr 2005; 94: 813. | ||
In article | View Article PubMed | ||
[98] | Ma JF, Tamai K, Yamaji N, Mitani N, Konishi S, Katsuhara M, et al. A silicon transporter in rice. Nature 2006; 440: 688-91. | ||
In article | View Article PubMed | ||
[99] | Kinrade SD, Balec RJ, Schach AS, Wang J, Knight CTG. The structure of aqueous pentaoxo silicon complexes with cis-1,2-dihydroxycyclopentane and furanoidic vicinal cis-diols. Dalt Trans 2004: 3241. | ||
In article | |||
[100] | Pruksa S, Siripinyanond A, Powell JJ, Jugdaohsingh R. Silicon balance in human volunteers; a pilot study to establish the variance in silicon excretion versus intake. Nutr Metab (Lond) 2014; 11: 4. | ||
In article | View Article PubMed PubMed | ||
[101] | Jugdaohsingh R, Sripanyakorn S, Powell JJ. Silicon absorption and excretion is independent of age and sex in adults. Br J Nutr 2013; 110: 1024-30. | ||
In article | View Article PubMed | ||
[102] | Goodman S. Therapeutic effects of organic germanium. Med Hypotheses 1988; 26: 207-15. | ||
In article | View Article | ||
[103] | Jung M, Jung BG, Cha S Bin, Shin MK, Lee WJ, Shin SW, et al. The effects of Germanium biotite supplement as a prophylactic agent against respiratory infection in calves. Pak Vet J 2012; 32: 319-24. | ||
In article | |||
[104] | Choline-stabilised orthosilicic acid added for nutritional purposes to food supplements. EFSA J 2009; 7: 948. | ||
In article | View Article | ||
[105] | Araújo LA de, Addor F, Campos PMBGM. Use of silicon for skin and hair care: an approach of chemical forms available and efficacy. An Bras Dermatol 2016; 91: 331-5. | ||
In article | View Article PubMed PubMed | ||
[106] | Dobrzyński D, Boguszewska-Czubara A, Sugimori K. Hydrogeochemical and biomedical insights into germanium potential of curative waters: a case study of health resorts in the Sudetes Mountains (Poland). Environ Geochem Health 2018; 40: 1355-75. | ||
In article | View Article PubMed PubMed | ||
[107] | Kondratska OA, Grushka NG, Kaplunenko VG, Pavlovych SI, Sribna VO, Yanchii RI. Protective effect of germanium citrate in endotoxin-induced ovarian dysfunction in mice. Medicni Perspekt (Medical Perspect 2018; 23: 71-7. | ||
In article | View Article | ||
[108] | Ulbricht CE. Natural Standard Herb & Supplement Guide. 1st ed. Missouri, USA: Mosby. Elsevier; 2010. | ||
In article | |||
[109] | Sithole SC, Mugivhisa LL, Amoo SO, Olowoyo JO. Pattern and concentrations of trace metals in mushrooms harvested from trace metal-polluted soils in Pretoria, South Africa. South African J Bot 2017; 108: 315-20. | ||
In article | View Article | ||
[110] | Borovička J, Kubrová J, Rohovec J, Řanda Z, Dunn CE. Uranium, thorium and rare earth elements in macrofungi: What are the genuine concentrations? BioMetals 2011; 24: 837-45. | ||
In article | View Article PubMed | ||
[111] | Levine SA. Organic Germanium A Novel Dramatic Immunostimulant. J Orthomol Med 1987; 2: 83-7. | ||
In article | |||
[112] | Asai K. Miracle Cure: Organic Germanium. Japan Publications; 1980. | ||
In article | PubMed | ||
[113] | Schroeder HA. Serum Cholesterol Levels in Rats Fed Thirteen Trace Elements. J Nutr 1968; 94: 475-80. | ||
In article | View Article PubMed | ||
[114] | International Organization for Standardization. INTERNATIONAL STANDARD and metalloids in airborne particulate. Geneva: 2012. | ||
In article | |||
[115] | Furst A. Biological Testing of Germanium. Toxicol Ind Health 1987; 3: 167-204. | ||
In article | View Article PubMed | ||
[116] | Chenghom O, Suksringar J, Morakot N. Mineral Composition and Germanium Contents in Some Phellinus Mushrooms in the Northeast of Thailand. Curr Res Chem 2010; 2: 24-34. | ||
In article | View Article | ||
[117] | Dhingra HM, Umsawasdi T, Chiuten DF, Murphy WK, Holoye PY, Spitzer G, et al. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer. Cancer Treat Rep 1986; 70: 673-4. | ||
In article | PubMed | ||
[118] | Bhatti FUR, Kim SJ, Yi A-K, Hasty KA, Cho H. Cytoprotective role of vitamin E in porcine adipose-tissue-derived mesenchymal stem cells against hydrogen-peroxide-induced oxidative stress. Cell Tissue Res 2018; 374: 111-20. | ||
In article | View Article PubMed | ||
[119] | Li L, Ruan T, Lyu Y, Wu B. Advances in Effect of Germanium or Germanium Compounds on Animals—A Review. J Biosci Med 2017; 05: 56-73. | ||
In article | View Article | ||
[120] | Nakamura T, Takeda T, Tokuji Y. The Oral Intake of Organic Germanium, Ge-132, Elevates α-Tocopherol Levels in the Plas-ma and Modulates Hepatic Gene Expression Profiles to Promote Immune Activation in Mice. Int J Vitam Nutr Res 2014; 84: 0183-95. | ||
In article | View Article PubMed | ||
[121] | Schroeder HA, Kanisawa M, Frost D V., Mitchener M. Germanium, Tin and Arsenic in Rats: Effects on growth, survival, pathological lesions and life span. J Nutr 1968; 96: 37-45. | ||
In article | View Article | ||
[122] | Cheong YH, Kim SU, Seo DC, Chang NI, Lee JB, Park JH, et al. Effect of Inorganic and Organic Germanium Treatments on the Growth of Lettuce (Lactuca sativa). J Korean Soc Appl Biol Chem 2009; 52: 389-96. | ||
In article | View Article | ||
[123] | Qu L, Li S, Zhuo Y, Chen J, Qin X, Guo G. Anticancer effect of triterpenes from Ganoderma�lucidum�in human prostate cancer cells. Oncol Lett 2017; 14: 7467-72. | ||
In article | View Article | ||
[124] | Nakamura T, Nagura T, Akiba M, Sato K, Tokuji Y, Ohnishi M, et al. Promotive Effects of the Dietary Organic Germanium Poly-trans-[(2-carboxyethyl) germasesquioxane] (Ge-132) on the Secretion and Antioxidative Activity of Bile in Rodents. J Heal Sci 2010; 56: 72-80. | ||
In article | View Article | ||
[125] | NAKAMURA T, NAGURA T, SATO K, OHNISHI M. Evaluation of the Effects of Dietary Organic Germanium, Ge-132, and Raffinose Supplementation on Caecal Flora in Rats. Biosci Microbiota, Food Heal 2012; 31: 37-45. | ||
In article | View Article PubMed PubMed | ||
[126] | Krystek P, Ritsema R. Analytical product study of germanium-containing medicine by different ICP-MS applications. J Trace Elem Med Biol 2004; 18: 9-16. | ||
In article | View Article PubMed | ||
[127] | Sliva D. Medicinal mushroom Phellinus linteus as an alternative cancer therapy. Exp Ther Med 2010; 1: 407-11. | ||
In article | View Article PubMed PubMed | ||
[128] | Lai W-F, Lin M, Tang G, Lai W-F, Lin MC, Tang G. A Phytochemical-Based Copolymer Derived from Coriolus versicolor Polysaccharopeptides for Gene Delivery. Molecules 2018; 23: 2273. | ||
In article | View Article PubMed PubMed | ||
[129] | Nakamura T, Saito M, Aso H. Effects of a lactobacilli, oligosaccharide and organic germanium intake on the immune responses of mice. Biosci Biotechnol Biochem 2012; 76: 375-7. | ||
In article | View Article PubMed | ||
[130] | Schauss AG. Nephrotoxicity in humans by the ultratrace element germanium. Ren Fail 1991; 13: 1-4. | ||
In article | View Article PubMed | ||
[131] | Krapf R, Schaffner T, Iten PX. Abuse of Germanium Associated with Fatal Lactic Acidosis. Nephron 1992; 62: 351-6. | ||
In article | View Article PubMed | ||
[132] | Raisin J, Hess B, Blatter M, Zimmermann A, Descoeudres C, Horber FF, et al. [Toxicity of an organic Germanium compound: deleterious consequences of a " natural remedy" ]. Schweiz Med Wochenschr 1992; 122: 11-3. | ||
In article | PubMed | ||
[133] | Tao S-H, Bolger PM. Hazard Assessment of Germanium Supplements. Regul Toxicol Pharmacol 1997; 25: 211-9. | ||
In article | View Article PubMed | ||
[134] | Sabbioni E, Fortaner S, Bosisio S, Farina M, Del Torchio R, Edel J, et al. Metabolic fate of ultratrace levels of GeCl 4 in the rat and in vitro studies on its basal cytotoxicity and carcinogenic potential in Balb/3T3 and HaCaT cell lines. J Appl Toxicol 2010; 30: 34-41. | ||
In article | View Article PubMed | ||
Published with license by Science and Education Publishing, Copyright © 2019 Ferrão J, Bell V, Chaquisse E, Garrine C and Fernandes T
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/
[1] | Badalyan SM. Potential of mushroom bioactive molecules to develop healthcare biotech products. Proc 8th Int Conf Mushroom Biol Mushroom Prod 2014: 373-8. | ||
In article | |||
[2] | Valverde ME, Hernández-Perez T, Paredes-López O. Edible mushrooms: improving human health and promoting quality life. Int J Microbiol 2013; 2015: 1-14. | ||
In article | View Article PubMed PubMed | ||
[3] | Wasser S. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomed J 2014; 37: 345. | ||
In article | View Article PubMed | ||
[4] | Gibson GR, Probert HM, Loo J Van, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259. | ||
In article | View Article PubMed | ||
[5] | Caporgno MP, Mathys A. Trends in Microalgae Incorporation Into Innovative Food Products With Potential Health Benefits. Front Nutr 2018; 5: 1-10. | ||
In article | View Article PubMed PubMed | ||
[6] | Patel S, Goyal A. The current trends and future perspectives of prebiotics research: a review. 3 Biotech 2012; 2: 115-25. | ||
In article | View Article PubMed | ||
[7] | Singdevsachan SK, Auroshree P, Mishra J, Baliyarsingh B, Tayung K, Thatoi H. Mushroom polysaccharides as potential prebiotics with their antitumor and immunomodulating properties: A review. Bioact Carbohydrates Diet Fibre 2016; 7: 1-14. | ||
In article | View Article | ||
[8] | Rahar S, Swami G, Nagpal N, Nagpal M, Singh G. Preparation, characterization, and biological properties of β-glucans. J Adv Pharm Technol Res 2011; 2: 94. | ||
In article | View Article PubMed PubMed | ||
[9] | Ortiz LT, Rodríguez ML, Alzueta C, Rebolé A, Treviño J. Effect of inulin on growth performance, intestinal tract sizes, mineral retention and tibial bone mineralisation in broiler chickens. Br Poult Sci 2009; 50: 325-32. | ||
In article | View Article PubMed | ||
[10] | Zhang TY, Liu JL, Zhang J, Zhang N, Yang X, Qu H, et al. Effects of Dietary Zinc Levels on the Growth Performance, Organ Zinc Content, and Zinc Retention in Broiler Chickens. Brazilian J Poult Sci 2018; 20: 127-32. | ||
In article | View Article | ||
[11] | Alonso J, García MA, Pérez-López M, Melgar MJ. The concentrations and bioconcentration factors of copper and zinc in edible mushrooms. Arch Environ Contam Toxicol 2003; 44: 180-8. | ||
In article | View Article PubMed | ||
[12] | Davis HC. Can the gastrointestinal microbiota be modulated by dietary fibre to treat obesity? Ir J Med Sci 2018; 187: 393-402. | ||
In article | View Article PubMed | ||
[13] | Fesel PH, Zuccaro A. β-glucan: Crucial component of the fungal cell wall and elusive MAMP in plants. Fungal Genet Biol 2016; 90: 53-60. | ||
In article | View Article PubMed | ||
[14] | Lemieszek M, Rzeski W. Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Wspolczesna Onkol 2012; 16: 285-9. | ||
In article | View Article PubMed PubMed | ||
[15] | El Khoury D, Cuda C, Luhovyy BL, Anderson GH. Beta glucan: Health benefits in obesity and metabolic syndrome. J Nutr Metab 2012; 2012. | ||
In article | |||
[16] | Ren L, Perera C, Hemar Y. Antitumor activity of mushroom polysaccharides: a review. Food Funct 2012; 3: 1118. | ||
In article | View Article PubMed | ||
[17] | Synytsya A, Míčková K, Synytsya A, Jablonský I, Spěváček J, Erban V, et al. Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii: Structure and potential prebiotic activity. Carbohydr Polym 2009; 76: 548-56. | ||
In article | View Article | ||
[18] | Kim SP, Kang MY, Kim JH, Nam SH, Friedman M. Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice. J Agric Food Chem 2011; 59: 9861-9. | ||
In article | View Article PubMed | ||
[19] | Vaz JA, Heleno SA, Martins A, Almeida GM, Vasconcelos MH, Ferreira ICFR. Wild mushrooms Clitocybe alexandri and Lepista inversa: In vitro antioxidant activity and growth inhibition of human tumour cell lines. Food Chem Toxicol 2010; 48: 2881-4. | ||
In article | View Article PubMed | ||
[20] | Akramiene D, Kondrotas A, Didziapetriene J, Kevelaitis E. Effects of beta-glucans on the immune system. Medicina (Kaunas) 2007; 43: 597-606. | ||
In article | View Article | ||
[21] | Chang ST, Buswell JA. Mushroom nutriceuticals. World J Microbiol Biotechnol 1996; 12: 473-6. | ||
In article | View Article PubMed | ||
[22] | Tomita M, Miwa M, Ouchi S, Oda T, Aketagawa J, Goto Y, et al. Nonlinear intestinal absorption of (1-->3)-beta-D-glucan caused by absorptive and secretory transporting system. Biol Pharm Bull 2009; 32: 1295-7. | ||
In article | View Article PubMed | ||
[23] | Georgia Department of Public Health. Contribution of inflammation to several diseases. Stat Georg 2017. https://www.statistics.ge/statistics-on-inflammation/(accessed March 23, 2018). | ||
In article | |||
[24] | Grigg JB, Sonnenberg GF. Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases. J Immunol 2017; 198: 564-71. | ||
In article | View Article PubMed PubMed | ||
[25] | Senghor B, Sokhna C, Ruimy R, Lagier J-C. Gut microbiota diversity according to dietary habits and geographical provenance. Hum Microbiome J 2018; 7-8: 1-9. | ||
In article | View Article | ||
[26] | Thorburn AN, Macia L, Mackay CR. Diet, Metabolites, and “Western-Lifestyle” Inflammatory Diseases. Immunity 2014; 40: 833-42. | ||
In article | View Article PubMed | ||
[27] | Silva V de O, Pereira LJ, Murata RM. Oral microbe-host interactions: influence of β-glucans on gene expression of inflammatory cytokines and metabolome profile. BMC Microbiol 2017; 17: 53. | ||
In article | View Article PubMed PubMed | ||
[28] | North CJ, Venter CS, Jerling JC. The effects of dietary fibre on C-reactive protein, an inflammation marker predicting cardiovascular disease. Eur J Clin Nutr 2009; 63: 921-33. | ||
In article | View Article PubMed | ||
[29] | Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018; 9: 7204-18. | ||
In article | View Article | ||
[30] | Scully C, Georgakopoulou EA, Hassona Y. The Immune System: Basis of so much Health and Disease: 3. Adaptive Immunity. Dent Update 2017; 44: 322-4, 327. | ||
In article | View Article PubMed | ||
[31] | Heiman ML, Greenway FL. A healthy gastrointestinal microbiome is dependent on dietary diversity. Mol Metab 2016; 5: 317-20. | ||
In article | View Article PubMed PubMed | ||
[32] | Soty M, Penhoat A, Amigo-Correig M, Vinera J, Sardella A, Vullin-Bouilloux F, et al. A gut-brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic health. Mol Metab 2015; 4: 106-17. | ||
In article | View Article PubMed PubMed | ||
[33] | Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, et al. The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. Microbiol Mol Biol Rev 2017; 81. | ||
In article | View Article | ||
[34] | Trovato A, Pennisi M, Crupi R, Paola R Di, Alario A, Modafferi S, et al. Neuroinflammation and Mitochondrial Dysfunction in the Pathogenesis of Alzheimer’s Disease: Modulation by Coriolus Versicolor (Yun-Zhi) Nutritional Mushroom. J Neurol Neuromed 2017; 2: 19-28. | ||
In article | View Article | ||
[35] | Annison EF, Bryden WL. Perspectives on ruminant nutrition and metabolism I. Metabolism in the Rumen. Nutr Res Rev 1998; 11: 173-98. | ||
In article | View Article PubMed | ||
[36] | David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-63. | ||
In article | View Article PubMed PubMed | ||
[37] | Ohira H, Tsutsui W, Fujioka Y. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? J Atheroscler Thromb 2017; 24: 660-72. | ||
In article | View Article PubMed PubMed | ||
[38] | Hur KY, Lee MS. Gut Microbiota and Metabolic Disorders. Diabetes Metab J 2015; 39: 198-203. | ||
In article | View Article PubMed PubMed | ||
[39] | den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013; 54: 2325-40. | ||
In article | View Article PubMed PubMed | ||
[40] | Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health. Front Microbiol 2016; 7: 185. | ||
In article | View Article PubMed PubMed | ||
[41] | Tuncil YE, Thakkar RD, Marcia ADR, Hamaker BR, Lindemann SR. Divergent short-chain fatty acid production and succession of colonic microbiota arise in fermentation of variously-sized wheat bran fractions. Sci Rep 2018; 8: 16655. | ||
In article | View Article PubMed PubMed | ||
[42] | Defois C, Ratel J, Garrait G, Denis S, Le Goff O, Talvas J, et al. Food Chemicals Disrupt Human Gut Microbiota Activity And Impact Intestinal Homeostasis As Revealed By In Vitro Systems. Sci Rep 2018; 8: 11006. | ||
In article | View Article PubMed PubMed | ||
[43] | Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, Nebot C, Cardelle-Cobas A, Franco CM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota—a review. J Physiol Biochem 2018; 74: 69-83. | ||
In article | View Article PubMed | ||
[44] | Jiang H, Zhang X, Yu Z, Zhang Z, Deng M, Zhao J, et al. Altered gut microbiota profile in patients with generalized anxiety disorder. J Psychiatr Res 2018; 104: 130-6. | ||
In article | View Article PubMed | ||
[45] | Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, et al. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer Res 2017; 77: 1783-812. | ||
In article | View Article PubMed PubMed | ||
[46] | O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7: 688-93. | ||
In article | View Article PubMed PubMed | ||
[47] | Shenhav L, Furman O, Mizrahi I, Halperin E. Modeling the temporal dynamics of the gut microbial community in adults and infants. BioRxiv 2017: 212993. | ||
In article | View Article | ||
[48] | Sung J, Kim S, Cabatbat JJT, Jang S, Jin Y-S, Jung GY, et al. Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis. Nat Commun 2017; 8: 15393. | ||
In article | View Article PubMed PubMed | ||
[49] | de Jesus Raposo MF, de Morais AMMB, de Morais RMSC. Emergent Sources of Prebiotics: Seaweeds and Microalgae. Mar Drugs 2016; 14. | ||
In article | View Article | ||
[50] | Yamaguchi M, Yang Y, Ando M, Kumrungsee T, Kato N, Okazaki Y. Increased intestinal ethanol following consumption of fructooligosaccharides in rats. Biomed Reports 2018; 9: 427-32. | ||
In article | View Article | ||
[51] | Hozová B, Kuniak Ľ, Kelemenová B. Application of beta-D-glucans isolated from mushrooms Pleurotus ostreatus (Pleuran) and Lentinus edodes (Lentinan) for increasing the bioactivity of yoghurts. Czech J Food Sci 2011; 22: 204-14. | ||
In article | View Article | ||
[52] | Ayeka PA. Potential of Mushroom Compounds as Immunomodulators in Cancer Immunotherapy: A Review. Evidence-Based Complement Altern Med 2018; 2018: 1-9. | ||
In article | View Article PubMed PubMed | ||
[53] | Wang Y. Prebiotics: Present and future in food science and technology. Food Res Int 2009; 42: 8-12. | ||
In article | View Article | ||
[54] | Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (basidiomycetes: polyporaceae). Gen Pharmacol 1998; 30: 1-4. | ||
In article | View Article | ||
[55] | Saleh MH, Rashedi I, Keating A. Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide. Front Immunol 2017; 8: 1087. | ||
In article | View Article PubMed PubMed | ||
[56] | Chatterjee S, Biswas G, Basu SK, Acharya K. Antineoplastic effect of mushrooms: A review. Aust J Crop Sci 2011; 5: 904-11. | ||
In article | |||
[57] | Barros AB, Ferrão J, Fernandes T. A safety assessment of Coriolus versicolor biomass as a food supplement. Food & Nutrition Res 2016; 60: 1-7. | ||
In article | View Article PubMed PubMed | ||
[58] | Javanmard A, Ashtari S, Sabet B, Davoodi SH, Rostami-Nejad M, Esmaeil Akbari M, et al. Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview. Gastroenterol Hepatol from Bed to Bench 2018; 11: 284-95. | ||
In article | PubMed PubMed | ||
[59] | Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am J Clin Nutr 2001; 73: 399s-405s. | ||
In article | View Article PubMed | ||
[60] | Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 2001; 413: 36-7. | ||
In article | View Article PubMed | ||
[61] | Larone DH. Medically important fungi. 4th ed. USA: 2002. | ||
In article | PubMed | ||
[62] | Pandey KR, Naik SR, Vakil B V. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol 2015; 52: 7577-87. | ||
In article | View Article PubMed PubMed | ||
[63] | Barclay D V., Schrezenmeir J, Scholz-Ahrens KE, Adolphi B, Açil Y, Rochat F, et al. Effects of probiotics, prebiotics, and synbiotics on mineral metabolism in ovariectomized rats — impact of bacterial mass, intestinal absorptive area and reduction of bone turn-over. NFS J 2016; 3: 41-50. | ||
In article | View Article | ||
[64] | Jayachandran M, Chen J, Chung SSM, Xu B. A critical review on the impacts of β-glucans on gut microbiota and human health. J Nutr Biochem 2018; 61: 101-10. | ||
In article | View Article PubMed | ||
[65] | Khan AA, Gani A, Khanday FA, Masoodi FA. Biological and pharmaceutical activities of mushroom β-glucan discussed as a potential functional food ingredient. Bioact Carbohydrates Diet Fibre 2018; 16: 1-13. | ||
In article | View Article | ||
[66] | Ercolini D, Fogliano V. Food Design To Feed the Human Gut Microbiota. J Agric Food Chem 2018; 66: 3754-8. | ||
In article | View Article PubMed PubMed | ||
[67] | Shanahan F, van Sinderen D, O’Toole PW, Stanton C. Feeding the microbiota: transducer of nutrient signals for the host. Gut 2017; 66: 1709-17. | ||
In article | View Article PubMed | ||
[68] | Nabhani Z, Hezaveh SJG, Razmpoosh E, Asghari-Jafarabadi M, Gargari BP. The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial. Diabetes Res Clin Pract 2018; 138: 149-57. | ||
In article | View Article PubMed | ||
[69] | Deshpande GC, Rao SC, Keil AD, Patole SK. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med 2011; 9: 92. | ||
In article | View Article PubMed PubMed | ||
[70] | Nicholson LB. The immune system. Essays Biochem 2016; 60: 275-301. | ||
In article | View Article PubMed PubMed | ||
[71] | Vetvicka V, Dvorak B, Vetvickova J, Richter J, Krizan J, Sima P, et al. Orally administered marine (1 → 3)-β-d-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 2007; 40: 291-8. | ||
In article | View Article PubMed | ||
[72] | Novak M, Vetvicka V. β -Glucans, History, and the Present: Immunomodulatory Aspects and Mechanisms of Action. J Immunotoxicol 2008; 5: 47-57. | ||
In article | View Article PubMed | ||
[73] | Tang J, Lin G, Langdon WY, Tao L, Zhang J. Regulation of C-Type Lectin Receptor-Mediated Antifungal Immunity. Front Immunol 2018; 9: 123. | ||
In article | View Article PubMed PubMed | ||
[74] | Guo Y, Chang Q, Cheng L, Xiong S, Jia X, Lin X, et al. C-Type Lectin Receptor CD23 Is Required for Host Defense against Candida albicans and Aspergillus fumigatus Infection. J Immunol 2018; 201: 2427-40. | ||
In article | View Article PubMed | ||
[75] | Bohn JA, BeMiller JN. (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym 1995; 28: 3-14. | ||
In article | View Article | ||
[76] | Albeituni SH, Yan J. The effects of β-glucans on dendritic cells and implications for cancer therapy. Anticancer Agents Med Chem 2013; 13: 689-98. | ||
In article | View Article | ||
[77] | Chan G, Chan W, Sze D. The effects of β-glucan on human immune and cancer cells. J Hematol Oncol 2009; 2: 25. | ||
In article | View Article PubMed PubMed | ||
[78] | Ruthes AC, Smiderle FR, Iacomini M. D-Glucans from edible mushrooms: A review on the extraction, purification and chemical characterization approaches. Carbohydr Polym 2015; 117: 753-61. | ||
In article | View Article PubMed | ||
[79] | So J-S. Roles of Endoplasmic Reticulum Stress in Immune Responses. Mol Cells 2018; 41: 705-16. | ||
In article | PubMed PubMed | ||
[80] | Cheung PCK. Mini-review on edible mushrooms as source of dietary fiber: Preparation and health benefits. Food Sci Hum Wellness 2013; 2: 162-6. | ||
In article | View Article | ||
[81] | Naimi S, Zirah S, Hammami R, Fernandez B, Rebuffat S, Fliss I. Fate and Biological Activity of the Antimicrobial Lasso Peptide Microcin J25 Under Gastrointestinal Tract Conditions. Front Microbiol 2018; 9: 1764. | ||
In article | View Article PubMed PubMed | ||
[82] | Lenfestey MW, Neu J. Gastrointestinal Development: Implications for Management of Preterm and Term Infants. Gastroenterol Clin North Am 2018; 47: 773-91. | ||
In article | View Article | ||
[83] | Chamidah A. Stability of prebiotic, laminaran oligosaccharide under food processing conditions. IOP Conf Ser Earth Environ Sci 2018; 137: 012069. | ||
In article | View Article | ||
[84] | Jeong S-Y, Kang S, Hua CS, Ting Z, Park S. Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats. Genes Nutr 2017; 12: 31. | ||
In article | View Article PubMed PubMed | ||
[85] | Falandysz J. Selenium in Edible Mushrooms. J Environ Sci Heal Part C 2008; 26: 256-99. | ||
In article | View Article PubMed | ||
[86] | Gucia M, Jarzyńska G, Rafał E, Roszak M, Kojta AK, Osiej I, et al. Multivariate analysis of mineral constituents of edible Parasol Mushroom (Macrolepiota procera) and soils beneath fruiting bodies collected from Northern Poland. Environ Sci Pollut Res 2012; 19: 416-31. | ||
In article | View Article PubMed PubMed | ||
[87] | Kitadai N, Maruyama S. Origins of building blocks of life: A review. Geosci Front 2018; 9: 1117-53. | ||
In article | View Article | ||
[88] | Roberts SJ, Szabla R, Todd ZR, Stairs S, Bučar D-K, Šponer J, et al. Selective prebiotic conversion of pyrimidine and purine anhydronucleosides into Watson-Crick base-pairing arabino-furanosyl nucleosides in water. Nat Commun 2018; 9: 4073. | ||
In article | View Article PubMed PubMed | ||
[89] | Jamnická G, Vál’ka J, Bublinec E. Heavy metal accumulation and distribution in forest understory herb species of Carpathian beech ecosystems. Chem Speciat Bioavailab 2013; 25: 209-15. | ||
In article | View Article | ||
[90] | Falandysz J, Mędyk M, Treu R. Bio-concentration potential and associations of heavy metals in Amanita muscaria (L.) Lam. from northern regions of Poland. Environ Sci Pollut Res Int 2018; 25: 25190-206. | ||
In article | View Article PubMed PubMed | ||
[91] | Falandysz J, Sapkota A, Dryżałowska A, Mędyk M, Feng X. Analysis of some metallic elements and metalloids composition and relationships in parasol mushroom Macrolepiota procera. Environ Sci Pollut Res Int 2017; 24: 15528-37. | ||
In article | View Article PubMed PubMed | ||
[92] | Bienert GP, Schüssler MD, Jahn TP, Jahn T. Metalloids: essential, beneficial or toxic? Major intrinsic proteins sort it out. Trends Biochem Sci 2008; 33: 20-6. | ||
In article | View Article PubMed | ||
[93] | Jugdaohsingh R. Silicon and bone health. J Nutr Health Aging 2007; 11: 99-110. | ||
In article | PubMed PubMed | ||
[94] | Nielsen FH. Update on the possible nutritional importance of silicon. J Trace Elem Med Biol 2014; 28: 379-82. | ||
In article | View Article PubMed | ||
[95] | Pérez-Granados AM, Vaquero MP. Silicon, aluminium, arsenic and lithium: essentiality and human health implications. J Nutr Health Aging 2002; 6: 154-62. | ||
In article | PubMed | ||
[96] | Sanders OI, Rensing C, Kuroda M, Mitra B, Rosen BP. Antimonite is accumulated by the glycerol facilitator GlpF in Escherichia coli. J Bacteriol 1997; 179: 3365-7. | ||
In article | View Article PubMed PubMed | ||
[97] | McNaughton SA, Bolton-Smith C, Mishra GD, Jugdaohsingh R, Powell JJ. Dietary silicon intake in post-menopausal women. Br J Nutr 2005; 94: 813. | ||
In article | View Article PubMed | ||
[98] | Ma JF, Tamai K, Yamaji N, Mitani N, Konishi S, Katsuhara M, et al. A silicon transporter in rice. Nature 2006; 440: 688-91. | ||
In article | View Article PubMed | ||
[99] | Kinrade SD, Balec RJ, Schach AS, Wang J, Knight CTG. The structure of aqueous pentaoxo silicon complexes with cis-1,2-dihydroxycyclopentane and furanoidic vicinal cis-diols. Dalt Trans 2004: 3241. | ||
In article | |||
[100] | Pruksa S, Siripinyanond A, Powell JJ, Jugdaohsingh R. Silicon balance in human volunteers; a pilot study to establish the variance in silicon excretion versus intake. Nutr Metab (Lond) 2014; 11: 4. | ||
In article | View Article PubMed PubMed | ||
[101] | Jugdaohsingh R, Sripanyakorn S, Powell JJ. Silicon absorption and excretion is independent of age and sex in adults. Br J Nutr 2013; 110: 1024-30. | ||
In article | View Article PubMed | ||
[102] | Goodman S. Therapeutic effects of organic germanium. Med Hypotheses 1988; 26: 207-15. | ||
In article | View Article | ||
[103] | Jung M, Jung BG, Cha S Bin, Shin MK, Lee WJ, Shin SW, et al. The effects of Germanium biotite supplement as a prophylactic agent against respiratory infection in calves. Pak Vet J 2012; 32: 319-24. | ||
In article | |||
[104] | Choline-stabilised orthosilicic acid added for nutritional purposes to food supplements. EFSA J 2009; 7: 948. | ||
In article | View Article | ||
[105] | Araújo LA de, Addor F, Campos PMBGM. Use of silicon for skin and hair care: an approach of chemical forms available and efficacy. An Bras Dermatol 2016; 91: 331-5. | ||
In article | View Article PubMed PubMed | ||
[106] | Dobrzyński D, Boguszewska-Czubara A, Sugimori K. Hydrogeochemical and biomedical insights into germanium potential of curative waters: a case study of health resorts in the Sudetes Mountains (Poland). Environ Geochem Health 2018; 40: 1355-75. | ||
In article | View Article PubMed PubMed | ||
[107] | Kondratska OA, Grushka NG, Kaplunenko VG, Pavlovych SI, Sribna VO, Yanchii RI. Protective effect of germanium citrate in endotoxin-induced ovarian dysfunction in mice. Medicni Perspekt (Medical Perspect 2018; 23: 71-7. | ||
In article | View Article | ||
[108] | Ulbricht CE. Natural Standard Herb & Supplement Guide. 1st ed. Missouri, USA: Mosby. Elsevier; 2010. | ||
In article | |||
[109] | Sithole SC, Mugivhisa LL, Amoo SO, Olowoyo JO. Pattern and concentrations of trace metals in mushrooms harvested from trace metal-polluted soils in Pretoria, South Africa. South African J Bot 2017; 108: 315-20. | ||
In article | View Article | ||
[110] | Borovička J, Kubrová J, Rohovec J, Řanda Z, Dunn CE. Uranium, thorium and rare earth elements in macrofungi: What are the genuine concentrations? BioMetals 2011; 24: 837-45. | ||
In article | View Article PubMed | ||
[111] | Levine SA. Organic Germanium A Novel Dramatic Immunostimulant. J Orthomol Med 1987; 2: 83-7. | ||
In article | |||
[112] | Asai K. Miracle Cure: Organic Germanium. Japan Publications; 1980. | ||
In article | PubMed | ||
[113] | Schroeder HA. Serum Cholesterol Levels in Rats Fed Thirteen Trace Elements. J Nutr 1968; 94: 475-80. | ||
In article | View Article PubMed | ||
[114] | International Organization for Standardization. INTERNATIONAL STANDARD and metalloids in airborne particulate. Geneva: 2012. | ||
In article | |||
[115] | Furst A. Biological Testing of Germanium. Toxicol Ind Health 1987; 3: 167-204. | ||
In article | View Article PubMed | ||
[116] | Chenghom O, Suksringar J, Morakot N. Mineral Composition and Germanium Contents in Some Phellinus Mushrooms in the Northeast of Thailand. Curr Res Chem 2010; 2: 24-34. | ||
In article | View Article | ||
[117] | Dhingra HM, Umsawasdi T, Chiuten DF, Murphy WK, Holoye PY, Spitzer G, et al. Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer. Cancer Treat Rep 1986; 70: 673-4. | ||
In article | PubMed | ||
[118] | Bhatti FUR, Kim SJ, Yi A-K, Hasty KA, Cho H. Cytoprotective role of vitamin E in porcine adipose-tissue-derived mesenchymal stem cells against hydrogen-peroxide-induced oxidative stress. Cell Tissue Res 2018; 374: 111-20. | ||
In article | View Article PubMed | ||
[119] | Li L, Ruan T, Lyu Y, Wu B. Advances in Effect of Germanium or Germanium Compounds on Animals—A Review. J Biosci Med 2017; 05: 56-73. | ||
In article | View Article | ||
[120] | Nakamura T, Takeda T, Tokuji Y. The Oral Intake of Organic Germanium, Ge-132, Elevates α-Tocopherol Levels in the Plas-ma and Modulates Hepatic Gene Expression Profiles to Promote Immune Activation in Mice. Int J Vitam Nutr Res 2014; 84: 0183-95. | ||
In article | View Article PubMed | ||
[121] | Schroeder HA, Kanisawa M, Frost D V., Mitchener M. Germanium, Tin and Arsenic in Rats: Effects on growth, survival, pathological lesions and life span. J Nutr 1968; 96: 37-45. | ||
In article | View Article | ||
[122] | Cheong YH, Kim SU, Seo DC, Chang NI, Lee JB, Park JH, et al. Effect of Inorganic and Organic Germanium Treatments on the Growth of Lettuce (Lactuca sativa). J Korean Soc Appl Biol Chem 2009; 52: 389-96. | ||
In article | View Article | ||
[123] | Qu L, Li S, Zhuo Y, Chen J, Qin X, Guo G. Anticancer effect of triterpenes from Ganoderma�lucidum�in human prostate cancer cells. Oncol Lett 2017; 14: 7467-72. | ||
In article | View Article | ||
[124] | Nakamura T, Nagura T, Akiba M, Sato K, Tokuji Y, Ohnishi M, et al. Promotive Effects of the Dietary Organic Germanium Poly-trans-[(2-carboxyethyl) germasesquioxane] (Ge-132) on the Secretion and Antioxidative Activity of Bile in Rodents. J Heal Sci 2010; 56: 72-80. | ||
In article | View Article | ||
[125] | NAKAMURA T, NAGURA T, SATO K, OHNISHI M. Evaluation of the Effects of Dietary Organic Germanium, Ge-132, and Raffinose Supplementation on Caecal Flora in Rats. Biosci Microbiota, Food Heal 2012; 31: 37-45. | ||
In article | View Article PubMed PubMed | ||
[126] | Krystek P, Ritsema R. Analytical product study of germanium-containing medicine by different ICP-MS applications. J Trace Elem Med Biol 2004; 18: 9-16. | ||
In article | View Article PubMed | ||
[127] | Sliva D. Medicinal mushroom Phellinus linteus as an alternative cancer therapy. Exp Ther Med 2010; 1: 407-11. | ||
In article | View Article PubMed PubMed | ||
[128] | Lai W-F, Lin M, Tang G, Lai W-F, Lin MC, Tang G. A Phytochemical-Based Copolymer Derived from Coriolus versicolor Polysaccharopeptides for Gene Delivery. Molecules 2018; 23: 2273. | ||
In article | View Article PubMed PubMed | ||
[129] | Nakamura T, Saito M, Aso H. Effects of a lactobacilli, oligosaccharide and organic germanium intake on the immune responses of mice. Biosci Biotechnol Biochem 2012; 76: 375-7. | ||
In article | View Article PubMed | ||
[130] | Schauss AG. Nephrotoxicity in humans by the ultratrace element germanium. Ren Fail 1991; 13: 1-4. | ||
In article | View Article PubMed | ||
[131] | Krapf R, Schaffner T, Iten PX. Abuse of Germanium Associated with Fatal Lactic Acidosis. Nephron 1992; 62: 351-6. | ||
In article | View Article PubMed | ||
[132] | Raisin J, Hess B, Blatter M, Zimmermann A, Descoeudres C, Horber FF, et al. [Toxicity of an organic Germanium compound: deleterious consequences of a " natural remedy" ]. Schweiz Med Wochenschr 1992; 122: 11-3. | ||
In article | PubMed | ||
[133] | Tao S-H, Bolger PM. Hazard Assessment of Germanium Supplements. Regul Toxicol Pharmacol 1997; 25: 211-9. | ||
In article | View Article PubMed | ||
[134] | Sabbioni E, Fortaner S, Bosisio S, Farina M, Del Torchio R, Edel J, et al. Metabolic fate of ultratrace levels of GeCl 4 in the rat and in vitro studies on its basal cytotoxicity and carcinogenic potential in Balb/3T3 and HaCaT cell lines. J Appl Toxicol 2010; 30: 34-41. | ||
In article | View Article PubMed | ||